Joseph B. Armes - 15 Jan 2025 Form 4 Insider Report for CSW INDUSTRIALS, INC. (CSWI)

Signature
/s/Luke E. Alverson, Attorney in Fact
Issuer symbol
CSWI
Transactions as of
15 Jan 2025
Net transactions value
-$378,320
Form type
4
Filing time
15 Jan 2025, 18:24:32 UTC
Previous filing
16 Dec 2024
Next filing
18 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSWI Common Stock Other $0 -1,500 -100% $0.000000 0 15 Jan 2025 JBA Family Partners, L.P. F1
transaction CSWI Common Stock Other $0 +150 +0.3% $0.000000 49,848 15 Jan 2025 Direct F1
transaction CSWI Common Stock Sale $37,538 -100 -0.2% $375.38 49,748 15 Jan 2025 Direct F2, F3
transaction CSWI Common Stock Sale $85,906 -228 -0.46% $376.78 49,520 15 Jan 2025 Direct F2, F4
transaction CSWI Common Stock Sale $49,492 -131 -0.26% $377.80 49,389 15 Jan 2025 Direct F2, F5
transaction CSWI Common Stock Sale $60,229 -159 -0.32% $378.80 49,230 15 Jan 2025 Direct F2, F6
transaction CSWI Common Stock Sale $138,682 -365 -0.74% $379.95 48,865 15 Jan 2025 Direct F2, F7
transaction CSWI Common Stock Sale $6,473 -17 -0.03% $380.78 48,848 15 Jan 2025 Direct F2
holding CSWI Common Stock 3,143 15 Jan 2025 by ESOP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CSWI Performance Rights 8,236 15 Jan 2025 Common Stock 8,236 Direct F8
holding CSWI Performance Rights 12,422 15 Jan 2025 Common Stock 12,422 Direct F9
holding CSWI Performance Rights 7,851 15 Jan 2025 Common Stock 7,851 Direct F10
holding CSWI Performance Rights 27,559 15 Jan 2025 Common Stock 27,559 Direct F11
holding CSWI Restricted Stock Units 19,685 15 Jan 2025 Common Stock 19,685 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 In connection with certain estate planning actions undertaken by the Reporting Person, JBA Family Partners, L.P. (the "Family LP") was dissolved in January 2025, and on January 15, 2025, the 1,500 shares of the Issuer's common stock held by the Family LP were distributed as follows: (i) 1,350 shares to various trusts for which the Reporting Person is neither a trustee nor a beneficiary; and (ii) 150 shares to the Reporting Person and his spouse, aligning with their prior 10% general partner interest in the Family LP. The reported transactions reflect the transfer, without additional consideration, of the Reporting Person's indirect beneficial ownership interest in the Issuer's common stock previously held by the Family LP' consistent with distributions described in the previous sentence.
F2 The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.05 to $375.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.30 to $377.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $377.42 to $378.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $378.48 to $379.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.77 to $380.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F8 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F9 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F10 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F11 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F12 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.